IndraLab
Statements
P5091 activates apoptotic process. 37 / 37
|
4
33
reach
"Notable examples include FOXO-DRI, which activates FOXO transcription factors involved in regulating the cell cycle and apoptosis [219]; UBX0101, known for its ability to selectively induce apoptosis in senescent cells, offering therapeutic promise for age-related diseasesm [219]; and P22077/P5091, which inhibit MDM2 to enhance P53 activity and promote the removal of senescent cells [220]."
eidos
"26 The E3 inhibitor lenalidomide , which targets MARCH 1 , has been used to treat hematologic malignancies ; 88 the DUB inhibitor curcumin destabilizes CSN5 and improves the efficacy of immunotherapy in breast cancer , melanoma , and colon cancer ; 53 P5091 , which targets USP7 , induces apoptosis in multiple myeloma cell lines.134 Given the success of these E3 inhibitors and DUB inhibitors , increasing efforts have been made to design and develop novel small molecule inhibitors that are expected to modulate immune checkpoint pathways ."
reach
"The IC50 of SHG-140 and T98G cells were 1.2 µM and 1.59 µM, respectively, when treated with P5091 for 48 h. Based on IC50, SHG-140 and T98G cells were treated with P5091 for 48 h at 1, 2, and 4 µM. To explore whether P5091 induced apoptosis in GBM cells, we used Annexin V-FITC/PI flow cytometry."
reach
"32 Our study here aimed to examine the effect of P5091 on antitumor immunity and its possible role in cancer immunotherapy.In our study, we found that P5091 promoted colon cancer cell apoptosis and death in CT26 xenografted mice and that the effect was similar when compared to an anti-PD-1-treated group."